GT Biopharma (GTBP)
NASDAQ:GTBP

GT Biopharma (GTBP) Stock Price & Analysis

171 Followers

GTBP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.18 - $2.30
Previous Close$0.25
Volume266.83K
Average Volume (3M)332.61K
Market Cap
$10.01M
Enterprise ValueN/A
Total Cash (Recent Filing)$17.97M
Total Debt (Recent Filing)$120.00K
Price to Earnings (P/E)-0.6
Beta1.01
Nov 16, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding40,639,688
10 Day Avg. Volume162,151
30 Day Avg. Volume332,613
Standard Deviation0.34
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.85
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio2502.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
Price Target Upside1900.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

GTBP FAQ

What was GT Biopharma’s price range in the past 12 months?
GT Biopharma lowest stock price was $0.18 and its highest was $2.30 in the past 12 months.
    What is GT Biopharma’s market cap?
    Currently, no data Available
    When is GT Biopharma’s upcoming earnings report date?
    GT Biopharma’s upcoming earnings report date is Nov 16, 2023 which is in 51 days.
      How were GT Biopharma’s earnings last quarter?
      GT Biopharma released its earnings results on Aug 07, 2023. The company reported -$0.055 earnings per share for the quarter, beating the consensus estimate of -$0.1 by $0.045.
        Is GT Biopharma overvalued?
        According to Wall Street analysts GT Biopharma’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does GT Biopharma pay dividends?
          GT Biopharma does not currently pay dividends.
          What is GT Biopharma’s EPS estimate?
          GT Biopharma’s EPS estimate is -$0.09.
            How many shares outstanding does GT Biopharma have?
            GT Biopharma has 40,639,687 shares outstanding.
              What happened to GT Biopharma’s price movement after its last earnings report?
              GT Biopharma reported an EPS of -$0.055 in its last earnings report, beating expectations of -$0.1. Following the earnings report the stock price went up 3.704%.
                Which hedge fund is a major shareholder of GT Biopharma?
                Currently, no hedge funds are holding shares in GTBP

                ---

                GT Biopharma Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                GT Biopharma

                GT Biopharma, Inc. is engages in the development and commercialization of novel immuno-oncology products. Its products include OXS-1550, OXS-1650, OXS-3550, OXS-4550, OXS-1750, OXS-1950, and OXS-2050. The company was founded in 1965 and is headquartered in Westlake Village, CA.

                ---

                Top 5 ETFs holding GTBP

                Name
                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                $209.97K
                8
                Up to five ETFs with an Outperform Smart Score that hold GTBP. The ETFs are listed according to market value of GTBP within the ETF

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                BioNano Genomics
                Advaxis
                Agenus

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis